European Journal of Dermatology
MENUTopical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors Volume 26, issue 1, January-February 2016
Tables
1 USF Sete Caminhos - ACeS Gondomar
2 Department of Dermatology, Centro Hospitalar do Porto, Rua D. Manuel II, s/n, 4099-001 Porto, Portugal
3 Unit for Multidisciplinary Research in Biomedicine, Instituto Ciências Biomédicas Abel Salazar, University of Porto, Portugal
* Reprints
- Key words: psoriasis, small molecules, topical therapy, JAK/STAT inhibitors, phosphodiesterase-4 inhibitors
- DOI : 10.1684/ejd.2015.2663
- Page(s) : 3-8
- Published in: 2016
Psoriasis is a common chronic and disabling skin disorder affecting approximately 2% of the population, associated with significant negative impact on the patient's quality of life [1]. Moreover, psoriasis has been associated with several comorbidities, such as psoriatic arthritis and cardiovascular disease [2, 3]. Plaque-type psoriasis is the most common form and is typically characterized by erythematous papules and plaques with a silver scale, usually localized on the elbows, knees, sacrum [...]